<!DOCTYPE html>
<html class="client-nojs" lang="en" dir="ltr">
<head>
<meta charset="UTF-8"/>
<title>Uveitic Glaucoma - EyeWiki</title>
<script>document.documentElement.className="client-js";RLCONF={"wgBreakFrames":!1,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"mdy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"ZAVjVbydbNjqe1d87p-WZwAAAAQ","wgCSPNonce":!1,"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":!1,"wgNamespaceNumber":0,"wgPageName":"Uveitic_Glaucoma","wgTitle":"Uveitic Glaucoma","wgCurRevisionId":83944,"wgRevisionId":83944,"wgArticleId":1340,"wgIsArticle":!0,"wgIsRedirect":!1,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Articles","Glaucoma"],"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Uveitic_Glaucoma","wgRelevantArticleId":1340,"wgIsProbablyEditable":!1,"wgRelevantPageIsProbablyEditable":!1,"wgRestrictionEdit":[],"wgRestrictionMove":[],"sdgDownArrowImage":
"/w/extensions/SemanticDrilldown/skins/down-arrow.png","sdgRightArrowImage":"/w/extensions/SemanticDrilldown/skins/right-arrow.png","wgCiteDrawerEnableDesktop":!1,"wgCiteDrawerEnableMobile":!0,"wgCiteDrawerTheme":"dark","wgPageFormsTargetName":null,"wgPageFormsAutocompleteValues":[],"wgPageFormsAutocompleteOnAllChars":!1,"wgPageFormsFieldProperties":[],"wgPageFormsCargoFields":[],"wgPageFormsDependentFields":[],"wgPageFormsCalendarValues":[],"wgPageFormsCalendarParams":[],"wgPageFormsCalendarHTML":null,"wgPageFormsGridValues":[],"wgPageFormsGridParams":[],"wgPageFormsContLangYes":null,"wgPageFormsContLangNo":null,"wgPageFormsContLangMonths":[],"wgPageFormsHeightForMinimizingInstances":800,"wgPageFormsShowOnSelect":[],"wgPageFormsScriptPath":"/w/extensions/PageForms","edgValues":[],"wgPageFormsEDSettings":null,"wgAmericanDates":!0,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"srfFilteredConfig":null,
"wgEditSubmitButtonLabelPublish":!1};RLSTATE={"site.styles":"ready","noscript":"ready","user.styles":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","mediawiki.ui.button":"ready","skins.chameleon":"ready","zzz.ext.bootstrap.styles":"ready","mediawiki.toc.styles":"ready","ext.CookieWarning.styles":"ready","oojs-ui-core.styles":"ready","oojs-ui.styles.indicators":"ready","mediawiki.widgets.styles":"ready","oojs-ui-core.icons":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.srf.styles":"ready","ext.smw.style":"ready","ext.smw.tooltip.styles":"ready"};RLPAGEMODULES=["ext.smw.style","ext.smw.tooltips","ext.cite.ux-enhancements","smw.entityexaminer","site","mediawiki.page.startup","mediawiki.page.ready","mediawiki.toc","ext.citedrawer.main","ext.CookieWarning","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.eyeWiki","ext.eyeWiki.slideshow","sentry.init","ext.bootstrap.scripts"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@1hzgi",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});
});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.CookieWarning.styles%7Cext.cite.styles%7Cext.visualEditor.desktopArticleTarget.noscript%7Cmediawiki.toc.styles%7Cmediawiki.ui.button%7Cmediawiki.widgets.styles%7Coojs-ui-core.icons%2Cstyles%7Coojs-ui.styles.indicators%7Cskins.chameleon%7Czzz.ext.bootstrap.styles&amp;only=styles&amp;skin=chameleon"/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.smw.style%7Cext.smw.tooltip.styles&amp;only=styles&amp;skin=chameleon"/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.srf.styles&amp;only=styles&amp;skin=chameleon"/>
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=chameleon"></script>
<style>#mw-indicator-mw-helplink {display:none;}</style>
<meta name="ResourceLoaderDynamicStyles" content=""/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=chameleon"/>
<meta name="generator" content="MediaWiki 1.35.8"/>
<meta name="description" content="Uveitic glaucoma is a common complication of uveitis affecting some 20% of patients.&amp;#160; The term uveitic glaucoma is used to describe glaucoma resulting indirectly or directly from uveitis.&amp;#160; Glaucoma is more commonly associated with anterior uveitis and with chronic forms of uveitis.&amp;#160; Uveitis and its treatment can lead to elevated intraocular pressure&amp;#160; (IOP).&amp;#160; A persistent rise in IOP can lead to glaucamatous optic neuropathy and visual field loss&amp;#91;1&amp;#93;. Intraocular pressure (IOP) elevation in uveitis can be secondary to open angle&amp;#160; or angle closure mechanisms.&amp;#160; It can also be to due corticosteroid induced glaucoma&amp;#91;2&amp;#93;. The pathogenesis may be acute in onset, with rapid onset inflammation, obstruction of intertrabecular spaces and subsequent increased IOP. The pathogenesis may also be chronic, with repeated bouts of uveitis leading to fibroblastic infiltration and formation of scar tissue that slowly obstructs the anterior chamber angle."/>
<meta name="date" content="2022-08-09"/>
<meta name="WT.seg_1" content="0"/>
<meta name="google-site-verification" content="mtQvMIGqpWB4oyYM5mux15MHU-3qWI0bWtyRa2b5rlk"/>
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"/>
<link rel="alternate" type="application/rdf+xml" title="Uveitic Glaucoma" href="/w/index.php?title=Special:ExportRDF/Uveitic_Glaucoma&amp;xmlmime=rdf"/>
<link rel="shortcut icon" href="/w/extensions/EyeWiki/favicons/favicon.ico"/>
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="EyeWiki (en)"/>
<link rel="EditURI" type="application/rsd+xml" href="https://eyewiki.org/w/api.php?action=rsd"/>
<link rel="preconnect" href="https://fonts.gstatic.com">
<link href="https://fonts.googleapis.com/css2?family=Lato:ital,wght@0,400;0,700;1,400&display=swap" rel="stylesheet">
<!-- Favicons MEYE-108 -->
<link rel="apple-touch-icon" sizes="120x120" href="/w/extensions/EyeWiki/favicons/apple-touch-icon.png">
<link rel="icon" type="image/png" sizes="32x32" href="/w/extensions/EyeWiki/favicons/favicon-32x32.png">
<link rel="icon" type="image/png" sizes="16x16" href="/w/extensions/EyeWiki/favicons/favicon-16x16.png">
<link rel="manifest" href="/w/extensions/EyeWiki/favicons/site.webmanifest">
<link rel="mask-icon" href="/w/extensions/EyeWiki/favicons/safari-pinned-tab.svg" color="#603cba">
<link rel="shortcut icon" href="/w/extensions/EyeWiki/favicons/favicon.ico">
<meta name="msapplication-TileColor" content="#603cba">
<meta name="msapplication-config" content="/w/extensions/EyeWiki/favicons/browserconfig.xml">
<meta name="theme-color" content="#ffffff">
<script> window.interdeal = { "sitekey": "81c701489fb8bb4ab90ca1cb0931f9c5", "Position": "Left", "Menulang": "EN", "domains": { "js": "https://cdn.equalweb.com/", "acc": "https://access.equalweb.com/" }, "btnStyle": { "vPosition": [ "80%", null ], "scale": [ "0.8", "0.8" ], "color": { "main": "#1876c9" }, "icon": { "type": 1, "outline": false } } }; (function(doc, head, body){ var coreCall = doc.createElement('script'); coreCall.src = 'https://cdn.equalweb.com/core/4.3.8/accessibility.js'; coreCall.defer = true; coreCall.integrity = 'sha512-u6i35wNTfRZXp0KDwSb3TntaIKI2ItCt/H/KcYIsBeVbaVMerEQLBnU5/ztfBg9aSW1gg7AN4CqCu9a455jkUg=='; coreCall.crossOrigin = 'anonymous'; coreCall.setAttribute('data-cfasync', true ); body? body.appendChild(coreCall) : head.appendChild(coreCall); })(document, document.head, document.body); </script>
<!--[if lt IE 9]><script src="/w/resources/lib/html5shiv/html5shiv.js"></script><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject page-Uveitic_Glaucoma rootpage-Uveitic_Glaucoma layout-standard skin-chameleon action-view">
	<div class="flex-fill container">
		<div class="row">
			<div class="flex-grow-0 col-12 col-cmln-6 d-flex flex-column flex-md-row w-md-100 justify-content-start align-items-center col">
					<div class="float-left mr-3 mb-2"><a href="//aao.org"><img id="aao-logo" src="/w/extensions/EyeWiki/skins/chameleon/AAO_Logo.png"></a></div>
                		
				<!-- logo and main page link -->
				<div id="p-logo" class="p-logo" role="banner">
					<a href="/Main_Page" title="Visit the main page"><img src="/w/extensions/EyeWiki/skins/chameleon/EyeWiki_Logo.png" alt="EyeWiki"/></a>
				</div>
			</div>
			<div class="ml-auto col-12 col-cmln col">
				<div class="row">
					<div class="col">
						<!-- personal tools -->
						<div class="p-personal pull-right" id="p-personal" >
							<ul class="p-personal-tools" >
								<li id="pt-createaccount"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=Uveitic+Glaucoma" title="You are encouraged to create an account and log in; however, it is not mandatory" class="pt-createaccount">Create account</a></li>
								<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Uveitic+Glaucoma" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o" class="pt-login">Log in</a></li>
							</ul>
						</div>

					</div>
				</div>
				<div class="row">
					<div class="col">
						<!-- search form -->
						<div  id="p-search" class="p-search pull-right" role="search"  >
							<form  id="searchform" class="mw-search" action="/w/index.php" >
								<input type="hidden" name="title" value=" Special:Search" />
								<div class="input-group">
									<input name="search" placeholder="Search EyeWiki" title="Search EyeWiki [f]" accesskey="f" id="searchInput" class="form-control"/>
									<div class="input-group-append">
										<button value="Go" id="searchGoButton" name="go" type="submit" class="search-btn searchGoButton" aria-label="Go to page" title="Go to a page with this exact name if it exists"></button>
									</div>
								</div>
							</form>
						</div>
					</div>
				</div>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- navigation bar -->
				<nav class="p-navbar collapsible mb-3 mt-2 p-1 mt-cmln-0" role="navigation" id="mw-navigation">
					<button type="button" class="navbar-toggler" data-toggle="collapse" data-target="#hbpzysaj2f"></button>
					<div class="collapse navbar-collapse hbpzysaj2f" id="hbpzysaj2f">
						<div class="navbar-nav"><div class="nav-item"><a class="nav-link fas fa-home"  href="/Main_Page">Main Page</a></div><div class="nav-item"><a class="nav-link fas fa-book"  href="/Category:Articles">Articles</a></div><div class="nav-item"><a class="nav-link fas fa-play"  href="/Help:Getting_Started">Getting Started</a></div><div class="nav-item"><a class="nav-link fas fa-question"  href="/Help:Contents">Help</a></div><div class="nav-item"><a class="nav-link fas fa-backward"  href="/Special:RecentChanges">Recent changes</a></div><div class="nav-item"><a class="nav-link fas fa-door-open"  href="#">My Portal</a></div>
						</div>
					</div>
				</nav>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- Content navigation -->
				<div class="mb-3 pagetools p-contentnavigation" id="p-contentnavigation">
					<!-- namespaces -->
					<div id="p-namespaces" class="p-namespaces">
						<div class="tab-group">
							<div id="ca-nstab-main" class="selected"><a href="/Uveitic_Glaucoma" title="View the content page [c]" accesskey="c" class="selected ca-nstab-main">Page</a></div>
							<div id="ca-talk" class="new"><a href="/w/index.php?title=Talk:Uveitic_Glaucoma&amp;action=edit&amp;redlink=1" rel="discussion" title="Discussion about the content page (page does not exist) [t]" accesskey="t" class="new ca-talk">Discussion</a></div>
						</div>
					</div>
					<!-- views -->
					<div id="p-views" class="p-views">
						<div class="tab-group">
							<div id="ca-formedit"><a href="/w/index.php?title=Uveitic_Glaucoma&amp;action=formedit" title="Edit this page with a form [&amp;]" accesskey="&amp;" class="ca-formedit">View form</a></div>
							<div id="ca-viewsource"><a href="/w/index.php?title=Uveitic_Glaucoma&amp;action=edit" title="This page is protected.&#10;You can view its source [e]" accesskey="e" class="ca-viewsource">View source</a></div>
							<div id="ca-history"><a href="/w/index.php?title=Uveitic_Glaucoma&amp;action=history" title="Past revisions of this page [h]" accesskey="h" class="ca-history">History</a></div>
						</div>
					</div>
				</div>
			</div>
		</div>
		<div class="row">
			<div class="col-auto mx-auto col">

			</div>
		</div>
		<div class="row">
			<div class="col-auto mx-auto col">
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- start the content area -->
				<div id="content" class="mw-body content"><a id="top" class="top"></a>
					<div id="mw-indicators" class="mw-indicators">
					<div id="mw-indicator-smw-entity-examiner" class="mw-indicator mw-indicator-smw-entity-examiner"><div class="smw-entity-examiner smw-indicator-vertical-bar-loader" data-subject="Uveitic_Glaucoma#0##" data-dir="ltr" data-uselang="" title="Running an examiner in the background"></div></div>
				</div>
						<div class="contentHeader">
						<!-- title of the page -->
						<h1 id="firstHeading" class="firstHeading">Uveitic Glaucoma</h1>
						<!-- tagline; usually goes something like "From WikiName" primary purpose of this seems to be for printing to identify the source of the content -->
						<div id="siteSub" class="siteSub">From EyeWiki</div><div id="jump-to-nav" class="mw-jump jump-to-nav">Jump to:<a href="#mw-navigation">navigation</a>, <a href="#p-search">search</a></div>
					</div>
					<div id="bodyContent" class="bodyContent">
						<!-- body text -->

						<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><div class="mw-parser-output"><div id="article-header" data-description2-ignore=""><div id="contest" style="margin-bottom: 6px;">
</div>
<div class="infobox contributors">
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header"><a href="/Property:Authors" title="Property:Authors">Article initiated by</a>:
</div>
<div class="info-section-body"><a href="/User:Babak.Eliassi-Rad" title="User:Babak.Eliassi-Rad">Babak Eliassi-Rad, MD</a>,&#8201;<a href="/w/index.php?title=User:Andrew_Francis&amp;action=formedit&amp;redlink=1" class="new" title="User:Andrew Francis (page does not exist)">Andrew Francis</a>
</div>
</div>
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">All authors and contributors:
</div>
<div class="info-section-body"> <a href="/User:JoAnn.A.Giaconi.CMT" title="User:JoAnn.A.Giaconi.CMT">JoAnn A. Giaconi, MD</a>,&#160;<a href="/User:Babak.Eliassi-Rad" title="User:Babak.Eliassi-Rad">Babak Eliassi-Rad, MD</a>,&#160;<a href="/User:Arsham.Sheybani" title="User:Arsham.Sheybani">Arsham Sheybani, MD</a>
</div>
</div>
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">Assigned editor:
</div>
<div class="info-section-body"> <a href="/User:Arsham.Sheybani" title="User:Arsham.Sheybani">Arsham Sheybani, MD</a></div>
</div><div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">Review:
</div>
<div class="info-section-body">Assigned status <b>Update Pending</b>
</div>
</div>&#160;by <a href="/User:Arsham.Sheybani" title="User:Arsham.Sheybani">Arsham Sheybani, MD</a> on August 10, 2022.
</div>
<div style="display:none;">
<table cellspacing="5">

<tbody><tr>
<td><small><a rel="nofollow" class="external text" href="https://eyewiki.org/w/index.php?title=Uveitic_Glaucoma&amp;action=formedit">add</a></small>
</td></tr>
<tr>
<th align="right"><b><a href="/Property:Contributing_Editors" title="Property:Contributing Editors">Contributing Editors</a>:</b>
</th>
<td><small><a rel="nofollow" class="external text" href="https://eyewiki.org/w/index.php?title=Uveitic_Glaucoma&amp;action=formedit">add</a></small>
</td></tr>
</tbody></table> </div>
<div style="display:none;">
<p><br />
</p>
</div>
<div id="local-videos">
</div>
</div>
<div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none" /><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Summary"><span class="tocnumber">1</span> <span class="toctext">Summary</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Background"><span class="tocnumber">2</span> <span class="toctext">Background</span></a></li>
<li class="toclevel-1 tocsection-3"><a href="#Prevalence"><span class="tocnumber">3</span> <span class="toctext">Prevalence</span></a></li>
<li class="toclevel-1 tocsection-4"><a href="#Pathophysiology"><span class="tocnumber">4</span> <span class="toctext">Pathophysiology</span></a></li>
<li class="toclevel-1 tocsection-5"><a href="#Diagnosis"><span class="tocnumber">5</span> <span class="toctext">Diagnosis</span></a></li>
<li class="toclevel-1 tocsection-6"><a href="#Management"><span class="tocnumber">6</span> <span class="toctext">Management</span></a></li>
<li class="toclevel-1 tocsection-7"><a href="#Medical_Therapy"><span class="tocnumber">7</span> <span class="toctext">Medical Therapy</span></a></li>
<li class="toclevel-1 tocsection-8"><a href="#Surgical_Treatment"><span class="tocnumber">8</span> <span class="toctext">Surgical Treatment</span></a></li>
<li class="toclevel-1 tocsection-9"><a href="#References"><span class="tocnumber">9</span> <span class="toctext">References</span></a></li>
</ul>
</div>

<h1><span class="mw-headline" id="Summary">Summary</span></h1>
<p>Uveitic glaucoma is a common complication of uveitis affecting some 20% of patients.&#160; The term uveitic glaucoma is used to describe glaucoma resulting indirectly or directly from uveitis.&#160; Glaucoma is more commonly associated with anterior uveitis and with chronic forms of uveitis.&#160; Uveitis and its treatment can lead to elevated intraocular pressure&#160; (IOP).&#160; A persistent rise in IOP can lead to glaucamatous optic neuropathy and visual field loss<sup id="cite_ref-bodh1_1-0" class="reference"><a href="#cite_note-bodh1-1">&#91;1&#93;</a></sup>. Intraocular pressure (IOP) elevation in uveitis can be secondary to open angle&#160; or angle closure mechanisms.&#160; It can also be to due corticosteroid induced glaucoma<sup id="cite_ref-armaly2_2-0" class="reference"><a href="#cite_note-armaly2-2">&#91;2&#93;</a></sup>. The pathogenesis may be acute in onset, with rapid onset inflammation, obstruction of intertrabecular spaces and subsequent increased IOP. The pathogenesis may also be chronic, with repeated bouts of uveitis leading to fibroblastic infiltration and formation of scar tissue that slowly obstructs the anterior chamber angle. 
</p><p>Management of uveitic glaucoma is two pronged.&#160; The etiology of uveitis must be idenitifed and treated.&#160; Next, the elevated IOP is treated, making sure to assess for steroid-induced ocular hypertension.&#160; Medical and surgical therapy can be used&#160; to fully treat the uveitis glaucoma.&#160; 
</p>
<h1><span class="mw-headline" id="Background">Background</span></h1>
<p>Joseph Beer is credited with first recognizing the association between uveitis and glaucoma in 1813 and described it as arthritic iritis<sup id="cite_ref-beer3_3-0" class="reference"><a href="#cite_note-beer3-3">&#91;3&#93;</a></sup>. Priestly Smith published the first modern classification nearly 70 years later in 1891<sup id="cite_ref-smith4_4-0" class="reference"><a href="#cite_note-smith4-4">&#91;4&#93;</a></sup>. 
</p>
<h1><span class="mw-headline" id="Prevalence">Prevalence</span></h1>
<p>The estimated prevalence of glaucoma due to uveitis varies according to source, but is estimated between 10 to 20% of cases, but can be as high as 46% in cases of severe chronic uveitis<sup id="cite_ref-netland5_5-0" class="reference"><a href="#cite_note-netland5-5">&#91;5&#93;</a></sup>.
</p>
<h1><span class="mw-headline" id="Pathophysiology">Pathophysiology</span></h1>
<p>The mechanism for ocular hypertension in the setting of chronic anterior chamber inflammation is similar in many respects to the pathogenesis believed to underlie primary open-angle glaucoma (POAG). However, in uveitic glaucoma, obstruction of the outflow pathways, comprising the uveal and juxtacannalicular trabecular meshwork structures, follows disruption of the blood aqueous barrier (BAB) due to inflammation rather than due to idiopathic causes as in POAG. This allows inflammatory cells to enter the anterior chamber and disrupt the aqueous outflow equilibrium<sup id="cite_ref-freddo6_6-0" class="reference"><a href="#cite_note-freddo6-6">&#91;6&#93;</a></sup>. These inflammatory cells are capable of physically obstructing the outflow TM, as well as producing cytotoxic agents that can lead to permanent scarring of the TM lamellae and endothelial cells which line Schlemm’s canal<sup id="cite_ref-roth7_7-0" class="reference"><a href="#cite_note-roth7-7">&#91;7&#93;</a></sup> <sup id="cite_ref-richardson8_8-0" class="reference"><a href="#cite_note-richardson8-8">&#91;8&#93;</a></sup>. Inflammatory cells are known to act by PGE1- and PGE-2 mediated biochemical pathways which can lead to breakdown of the BAB<sup id="cite_ref-chiang9_9-0" class="reference"><a href="#cite_note-chiang9-9">&#91;9&#93;</a></sup>. This may explain the similarities between uveitic glaucoma and corticosteroid induced glaucoma. Complications may include neovascularization of the anterior chamber angle with hemorrhage and worsening obstruction. 
</p>
<h1><span class="mw-headline" id="Diagnosis">Diagnosis</span></h1>
<p>Symptoms of acute onset uveitis include pain, blurry vision, headache, photophobia, and colored haloes. The following findings may be seen on slit lamp examination:&#160; keratic precipiates, band keratopathy (in chronic cases), epithelial dendrites, corneal stromal scarring, iris may show stromal atrophy, nodules, posterior synechiae, and neovascularization. Cell and flare will be noted in the anterior chamber.&#160; The lens may show increased pigment on the anterior capsule. The intraocular pressure may be low due to inflammation affecting the ciliary body's aqueous production or it may be high if there is decreased aqueous outflow.&#160; On gonioscopy PAS may be present. Fundus examination may show optic nerve damage, cupping, or other signs consistent with glaucoma. Other potential posterior segment findings include: cystoid macular edema, retinitis, perivascular sheathing, choroidal infiltrates, or retinal detachment. 
</p><p>Signs of glaucoma include elevated intraocular pressure, glaucomatous excavation of the optic nerve, retinal nerve fiber layer defects, glaucomatous visual field scotomas, pupillary block, and peripheral anterior synechaie.&#160; 
</p>
<h1><span class="mw-headline" id="Management">Management</span></h1>
<p>Patients presenting with uveitis should be worked up for underlying systemic causes.&#160; Assessment for arthritis, infections, mucosa or skin lesions, and cough may lead one to order targeted tests.&#160; Uveitides associated with glaucoma include ankylosing spondylitis (order HLA-B27, sacroiliac joint imaging), syphilis (order RPR or VDRL), tuberculosis (order quantiferon gold, PPD, Chest X-ray), sarcoidosis (order angiotensin converting enzyme and chest xray/CT scan). &#160;&#160; Specific ocular inflammations associated with a high rate of secondary glaucoma that should be considered in cases of uveitic glaucoma: include Fuch’s heterochromic iridocyclitis (FHIC), glaucomatocyclitic crisis or Possner-Schlossman syndrome, sarcoidosis, juvenile rhematoid arthritis (JRA), and herpetic keratouveitis.  
</p>
<h1><span class="mw-headline" id="Medical_Therapy">Medical Therapy</span></h1>
<p>Treatment of uveitic glaucoma depends on the clinical presentation, but ultimately is directed at control of ocular hypertension, treatment of ocular inflammation and diagnosing and treating systemic disease. The major objective is to provide the patient with symptomatic relief, protect the optic nerve from the damaging effects of persistent or acutely elevated IOP, and prevent posterior synechiae formation while reducing the risk of angle closure and subsequent need for surgical therapy.&#160; Finally, long term management is aimed and preventing future attacks via repeat uveitis. Medical therapy is utilized first and only in cases refractory to medical management is surgery considered. To control inflammation corticosteroids, cycloplegics, T-cell suppressors, and cytotoxic agents are employed (Table 1). To control ocular hypertension ocular hypotensive agents such as carbonic anhydrase inhibitors, alpha-2 adrenergic agonists, prostaglandins, and hyperosmotic agents are used (Table 2).&#160;&#160;Miotics are generally avoided in uveitic glaucoma since they can further break down the blood-aqeuous barrier.<br />
</p><p>Table 1 
</p><p><a href="/File:Treatment_of_Ocular_Inflammation.jpg" class="image" title="Table 1"><img alt="Table 1" src="/w/images/1/1/18/Treatment_of_Ocular_Inflammation.jpg" decoding="async" width="1007" height="594" /></a><br /> 
</p><p><br /> 
</p><p>Table 2 
</p><p><a href="/File:Medical_Treatment_of_Glaucoma.jpg" class="image" title="Table 2"><img alt="Table 2" src="/w/images/1/0/07/Medical_Treatment_of_Glaucoma.jpg" decoding="async" width="876" height="911" /></a> 
</p><p><br /> 
</p><p><br /> 
</p>
<h1><span class="mw-headline" id="Surgical_Treatment">Surgical Treatment</span></h1>
<p>Surgery is reserved for refractory cases of uveitic glaucoma unresponsive to maximal medical therapy, as well as for cases of acute angle closure glaucoma. Generally, it is best to avoid surgery during the acute inflammatory phase and always use the least invasive method possible.&#160; The surgical procedure of choice is a glaucoma drainage implant if there is active inflammation. Studies have shown that all 3 common types of valves (Ahmed, Baerveldt, and Molteno) are effective in lowering intraocular pressure and reducing the number of glaucoma medications<sup id="cite_ref-papadaki11_10-0" class="reference"><a href="#cite_note-papadaki11-10">&#91;10&#93;</a></sup>
<sup id="cite_ref-rachmiel12_11-0" class="reference"><a href="#cite_note-rachmiel12-11">&#91;11&#93;</a></sup><sup id="cite_ref-ceballos13_12-0" class="reference"><a href="#cite_note-ceballos13-12">&#91;12&#93;</a></sup><sup id="cite_ref-vuori14_13-0" class="reference"><a href="#cite_note-vuori14-13">&#91;13&#93;</a></sup>.&#160; Trabeculectomy with antiproliferative agent can be used in uncontrolled IOP cases, as well. In a retrospective study Ceballos et al<sup id="cite_ref-ceballos15_14-0" class="reference"><a href="#cite_note-ceballos15-14">&#91;14&#93;</a></sup> reported a success rate of 78% at 1 year and 62% at 2 years. In their study male gender was a risk factor for failure. 51% of phakic patients required cataract surgery. The trabeculectomy can fail postoperatively secondary to intense and persistent inflammation.&#160; In a report out of Japan, it was found that trabeculectomy done for uveitic glaucoma in eyes where the uveitis was inactive had a similar success rate to trabeculectomy done in POAG eyes<sup id="cite_ref-kaburaki16_15-0" class="reference"><a href="#cite_note-kaburaki16-15">&#91;15&#93;</a></sup>. In concomitant cases of cataract and uncontrolled IOP, phacotrabeculectomy with mitomycin C can be performed with good outcomes<sup id="cite_ref-park17_16-0" class="reference"><a href="#cite_note-park17-16">&#91;16&#93;</a></sup>. Nonpenetrating filtering surgery has been reported to be successful in surgical management of refractory cases<sup id="cite_ref-auer18_17-0" class="reference"><a href="#cite_note-auer18-17">&#91;17&#93;</a></sup> <sup id="cite_ref-al19_18-0" class="reference"><a href="#cite_note-al19-18">&#91;18&#93;</a></sup>. Goniotomy is an option in pediatric uveitic glaucoma cases<sup id="cite_ref-ho20_19-0" class="reference"><a href="#cite_note-ho20-19">&#91;19&#93;</a></sup>. There is no role for cyclophotocoagulation and laser trabeculoplasty in the management of uveitic glaucoma since these procedures are pro-inflammatory. <br /> 
</p><p>In secondary angle-closure glaucoma due to pupillary block, laser peripheral iridotomy (LPI) is usually the treatment of choice, however, the LPI may close secondary to inflammatory membranes with reccurence of the pupillary block.&#160; If there is active inflammation, a better treatment is a surgical iridotomy with posterior synechiolysis<sup id="cite_ref-kulkarni10_20-0" class="reference"><a href="#cite_note-kulkarni10-20">&#91;20&#93;</a></sup>.
</p>
<h1><span class="mw-headline" id="References">References</span></h1>
<div class="mw-references-wrap mw-references-columns"><ol class="references">
<li id="cite_note-bodh1-1"><span class="mw-cite-backlink"><a href="#cite_ref-bodh1_1-0">↑</a></span> <span class="reference-text">Bodh SA, Kumar V, Raina UK, et al. Inflammatory glaucoma. Oman J Ophthalmol 2011; 4:3-9.</span>
</li>
<li id="cite_note-armaly2-2"><span class="mw-cite-backlink"><a href="#cite_ref-armaly2_2-0">↑</a></span> <span class="reference-text">Armaly MF. Effect of corticosteroids on intraocular pressure and fluid dynamics. I. The effect of dexamethasone in the normal eyes. Arch Ophthalmol 1963;70:482.</span>
</li>
<li id="cite_note-beer3-3"><span class="mw-cite-backlink"><a href="#cite_ref-beer3_3-0">↑</a></span> <span class="reference-text">Beer GJ. Die Lehre v. d. Augenkrankheiten. Vienna. 1813;1:633.</span>
</li>
<li id="cite_note-smith4-4"><span class="mw-cite-backlink"><a href="#cite_ref-smith4_4-0">↑</a></span> <span class="reference-text">Smith P. The pathology and treatment of glaucoma. London: J and A Churchhill; 1891. </span>
</li>
<li id="cite_note-netland5-5"><span class="mw-cite-backlink"><a href="#cite_ref-netland5_5-0">↑</a></span> <span class="reference-text">Netland PA, Denton NC. Uveitic glaucoma. Contemp Ophthalmol 2006; 5:1-6.</span>
</li>
<li id="cite_note-freddo6-6"><span class="mw-cite-backlink"><a href="#cite_ref-freddo6_6-0">↑</a></span> <span class="reference-text">Freddo TF, Patterson MM, Scott DR. Influence of mercurial sulfhydryl agents on aqueous outflow pathway in enucleated human eyes. Invest Ophthalmol Vis Sci 1984; 25:278-85.</span>
</li>
<li id="cite_note-roth7-7"><span class="mw-cite-backlink"><a href="#cite_ref-roth7_7-0">↑</a></span> <span class="reference-text">Roth M, Simmons RJ. Glaucoma associated with precipitates on the trabecular meshwork. Ophthalmology 1979; 86:1613-9.</span>
</li>
<li id="cite_note-richardson8-8"><span class="mw-cite-backlink"><a href="#cite_ref-richardson8_8-0">↑</a></span> <span class="reference-text">Richardson TM, Hutchinson BT, Grant WM. The outflow tract in pigmentary glaucoma: a light and electron microscopic study. Arch Ophthalmol 1977; 95:1015-25.  </span>
</li>
<li id="cite_note-chiang9-9"><span class="mw-cite-backlink"><a href="#cite_ref-chiang9_9-0">↑</a></span> <span class="reference-text">Chiang TS, Thomas RP. Ocular hypertension following infusion of prostaglandin E1. Arch Ophthalmol 1972; 88:418-20.</span>
</li>
<li id="cite_note-papadaki11-10"><span class="mw-cite-backlink"><a href="#cite_ref-papadaki11_10-0">↑</a></span> <span class="reference-text">Papadaki TG, Zacharopoulos IP, Pasquale LR, et al. Long-term results of Ahmed glaucoma valve implantation for uveitic glaucoma. Am J Ophthalmol 2007; 144(1):62-69.</span>
</li>
<li id="cite_note-rachmiel12-11"><span class="mw-cite-backlink"><a href="#cite_ref-rachmiel12_11-0">↑</a></span> <span class="reference-text">Rachmiel R, Trope GE, Buys YM, et al. Ahmed glaucoma valve implantation in uvietic glaucoma versus open-angle glaucoma patients. Can J Ophthalmol 2008; 43(4):462-7. </span>
</li>
<li id="cite_note-ceballos13-12"><span class="mw-cite-backlink"><a href="#cite_ref-ceballos13_12-0">↑</a></span> <span class="reference-text">Ceballos EM, Parrish RK, Schiffman JC. Outcome of Baerveldt glaucoma drainage implants for the treatment of uveitic glaucoma. Ophthalmology 2002; 109(12):2256-60.</span>
</li>
<li id="cite_note-vuori14-13"><span class="mw-cite-backlink"><a href="#cite_ref-vuori14_13-0">↑</a></span> <span class="reference-text">Vuori ML. Molteno aqueous shunt as a primary surgical intervention for uveitic glaucoma:long-term results. Acta Ophthalmol 2010; 88(10);33-36.</span>
</li>
<li id="cite_note-ceballos15-14"><span class="mw-cite-backlink"><a href="#cite_ref-ceballos15_14-0">↑</a></span> <span class="reference-text">Ceballos EM, Beck AD, Lynn MJ. Trabeculectomy with antiproliferative agents in uveitic glaucoma. J Glaucoma 2002; 11(3):189-96.</span>
</li>
<li id="cite_note-kaburaki16-15"><span class="mw-cite-backlink"><a href="#cite_ref-kaburaki16_15-0">↑</a></span> <span class="reference-text">Kaburaki T, Koshino T, Kawashima H, et al.  Initial trabeculectomy with mitomycin C in eyes with uveitic glaucoma with inactive uveitis.  Eye 2009; 23(7):1509-17. </span>
</li>
<li id="cite_note-park17-16"><span class="mw-cite-backlink"><a href="#cite_ref-park17_16-0">↑</a></span> <span class="reference-text">Park UC, Ahn JK, Park KH, et al. Phacotrabeculectomy with mitomycin C in patients with uveitis. Am J Ophthalmol 2006; 142(6):1005-12.</span>
</li>
<li id="cite_note-auer18-17"><span class="mw-cite-backlink"><a href="#cite_ref-auer18_17-0">↑</a></span> <span class="reference-text">Auer C, Mermoud A, Herbort CP. Deep sclerectomy for the management of uncontrolled uveitic glaucoma: preliminary data. Klin Monbl Augenheilkd 2004; 221(5):339-42.</span>
</li>
<li id="cite_note-al19-18"><span class="mw-cite-backlink"><a href="#cite_ref-al19_18-0">↑</a></span> <span class="reference-text">Al Obeidan SA, Osman EA, Al-Muammar AM, et al. Efficacy and safety of deep sclerectomy in uvieitc glaucoma. Int Ophthalmol 2009; 29(5):367-72.</span>
</li>
<li id="cite_note-ho20-19"><span class="mw-cite-backlink"><a href="#cite_ref-ho20_19-0">↑</a></span> <span class="reference-text">Ho CL, Wong EY, Walton DS. Goniosurgery for glaucoma complicating chronic childhood uveitis. Arch Ophthalmol 2004; 122(6):838-844. </span>
</li>
<li id="cite_note-kulkarni10-20"><span class="mw-cite-backlink"><a href="#cite_ref-kulkarni10_20-0">↑</a></span> <span class="reference-text">Kulkarni A, Barton K. Uvieitc Glaucoma in Glaucoma Eds Shaarawy TM, Sherwood MB, Hitchings RA, and Crowston JG. Glaucoma. Vol 1. China: Saunders: 2009:(33)393-407. </span>
</li>
</ol></div>
<!-- 
NewPP limit report
Cached time: 20230306035149
Cache expiry: 86400
Dynamic content: false
Complications: [my_variables_no_cache]
[SMW] In‐text annotation parser time: 0.001 seconds
CPU time usage: 0.145 seconds
Real time usage: 0.505 seconds
Preprocessor visited node count: 686/1000000
Post‐expand include size: 5935/2097152 bytes
Template argument size: 1384/2097152 bytes
Highest expansion depth: 11/40
Expensive parser function count: 1/100
Unstrip recursion depth: 0/20
Unstrip post‐expand size: 7875/5000000 bytes
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00%  293.423      1 Template:Article
100.00%  293.423      1 -total
 82.51%  242.103      4 Template:Infobox_section
 35.03%  102.778      8 Template:UserLookup
  3.39%    9.950      1 Template:Review_expired
  2.00%    5.870      1 Template:Get_active_contest
  1.67%    4.901      1 Template:Infobox_begin
  1.40%    4.111      1 Template:Infobox_end
-->
</div></div><div class="printfooter">
Retrieved from "<a dir="ltr" href="https://eyewiki.org/w/index.php?title=Uveitic_Glaucoma&amp;oldid=83944">https://eyewiki.org/w/index.php?title=Uveitic_Glaucoma&amp;oldid=83944</a>"</div>

						<!-- end body text -->
						<!-- data blocks which should go somewhere after the body text, but not before the catlinks block-->
						<div id='mw-data-after-content'>
	<div class="mw-cookiewarning-container"><div class="mw-cookiewarning-text"><span>The Academy uses cookies to analyze performance and provide relevant personalized content to users of our website.</span></div><form method="POST"><div class='oo-ui-layout oo-ui-horizontalLayout'><span aria-disabled='false' class='oo-ui-widget oo-ui-widget-enabled oo-ui-buttonElement oo-ui-buttonElement-framed oo-ui-labelElement oo-ui-flaggedElement-progressive oo-ui-buttonWidget'><a role='button' tabindex='0' aria-disabled='false' href='https://www.aao.org/privacy-policy' rel='nofollow' class='oo-ui-buttonElement-button'><span class='oo-ui-iconElement-icon oo-ui-iconElement-noIcon oo-ui-image-progressive'></span><span class='oo-ui-labelElement-label'>Learn more</span><span class='oo-ui-indicatorElement-indicator oo-ui-indicatorElement-noIndicator oo-ui-image-progressive'></span></a></span><span aria-disabled='false' class='oo-ui-widget oo-ui-widget-enabled oo-ui-inputWidget oo-ui-buttonElement oo-ui-buttonElement-framed oo-ui-labelElement oo-ui-flaggedElement-primary oo-ui-flaggedElement-progressive oo-ui-buttonInputWidget'><button type='submit' tabindex='0' aria-disabled='false' name='disablecookiewarning' value='OK' class='oo-ui-inputWidget-input oo-ui-buttonElement-button'><span class='oo-ui-iconElement-icon oo-ui-iconElement-noIcon oo-ui-image-invert'></span><span class='oo-ui-labelElement-label'>Accept</span><span class='oo-ui-indicatorElement-indicator oo-ui-indicatorElement-noIndicator oo-ui-image-invert'></span></button></span></div></form></div>
</div>

					</div>
					<!-- category links -->
					<div id="catlinks" class="catlinks" data-mw="interface"><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/Special:Categories" title="Special:Categories">Categories</a>: <ul><li><a href="/Category:Articles" title="Category:Articles">Articles</a></li><li><a href="/Category:Glaucoma" title="Category:Glaucoma">Glaucoma</a></li></ul></div></div>
				</div>
			</div>
		</div>
	</div>
	<div class="mb-2 mt-4 footer container">
		<div class="row">
			<div class="col">
				<!-- navigation bar -->
				<nav class="p-navbar not-collapsible small mb-2" role="navigation" id="mw-navigation-hbpzysapvz">
					<div class="navbar-nav">
					<!-- toolbox -->
					<div id="t-whatlinkshere" class="nav-item"><a href="/Special:WhatLinksHere/Uveitic_Glaucoma" title="A list of all wiki pages that link here [j]" accesskey="j" class="nav-link t-whatlinkshere">What links here</a></div>
					<div id="t-recentchangeslinked" class="nav-item"><a href="/Special:RecentChangesLinked/Uveitic_Glaucoma" rel="nofollow" title="Recent changes in pages linked from this page [k]" accesskey="k" class="nav-link t-recentchangeslinked">Related changes</a></div>
					<div id="t-specialpages" class="nav-item"><a href="/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q" class="nav-link t-specialpages">Special pages</a></div>
					<div id="t-print" class="nav-item"><a href="javascript:print();" rel="alternate" title="Printable version of this page [p]" accesskey="p" class="nav-link t-print">Printable version</a></div>
					<div id="t-permalink" class="nav-item"><a href="/w/index.php?title=Uveitic_Glaucoma&amp;oldid=83944" title="Permanent link to this revision of the page" class="nav-link t-permalink">Permanent link</a></div>
					<div id="t-info" class="nav-item"><a href="/w/index.php?title=Uveitic_Glaucoma&amp;action=info" title="More information about this page" class="nav-link t-info">Page information</a></div>
					</div>
				</nav>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- footer links -->
				<div id="footer-info" class="footer-info">
					<!-- info -->
					<div> This page was last edited on August 15, 2022, at 09:12.</div>
					<div>This page has been accessed 140,360 times.</div>
				</div>
				<!-- places -->
				<div id="footer-places" class="footer-places">
					<div><a href="/EyeWiki:Privacy_policy" title="EyeWiki:Privacy policy">Privacy policy</a></div>
					<div><a href="/EyeWiki:About" title="EyeWiki:About">About EyeWiki</a></div>
					<div><a href="/EyeWiki:General_disclaimer" title="EyeWiki:General disclaimer">Disclaimers</a></div>
				</div>
			</div>
			<div class="col">
				<!-- footer icons -->
				<div id="footer-icons" class="justify-content-end footer-icons">
					<!-- poweredby -->
					<div><a href="https://www.mediawiki.org/"><img src="/w/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="/w/resources/assets/poweredby_mediawiki_132x47.png 1.5x, /w/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" loading="lazy"/></a></div>
					<div><a href="https://www.semantic-mediawiki.org/wiki/Semantic_MediaWiki"><img src="data:image/png;base64,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" alt="Powered by Semantic MediaWiki" class="smw-footer" width="88" height="31" loading="lazy"/></a></div>
				</div>
			</div>
		</div>
	</div>
<script src="https://www.googletagmanager.com/gtag/js?id=UA-64665049-1" async=""></script><script>
window.dataLayer = window.dataLayer || [];
function gtag(){dataLayer.push(arguments);}
gtag('js', new Date());
gtag('config', 'UA-64665049-1', {});
</script>

<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"smw":{"limitreport-intext-parsertime":0.001},"limitreport":{"cputime":"0.145","walltime":"0.505","ppvisitednodes":{"value":686,"limit":1000000},"postexpandincludesize":{"value":5935,"limit":2097152},"templateargumentsize":{"value":1384,"limit":2097152},"expansiondepth":{"value":11,"limit":40},"expensivefunctioncount":{"value":1,"limit":100},"unstrip-depth":{"value":0,"limit":20},"unstrip-size":{"value":7875,"limit":5000000},"timingprofile":["100.00%  293.423      1 Template:Article","100.00%  293.423      1 -total"," 82.51%  242.103      4 Template:Infobox_section"," 35.03%  102.778      8 Template:UserLookup","  3.39%    9.950      1 Template:Review_expired","  2.00%    5.870      1 Template:Get_active_contest","  1.67%    4.901      1 Template:Infobox_begin","  1.40%    4.111      1 Template:Infobox_end"]},"cachereport":{"timestamp":"20230306035149","ttl":86400,"transientcontent":false}}});mw.config.set({"wgBackendResponseTime":880});});</script></body>
</html>